Literature DB >> 27301518

Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment.

Nobuo Sanjo1, Satoko Kina, Yukiko Shishido-Hara, Yurie Nose, Satoru Ishibashi, Tetsuya Fukuda, Taketoshi Maehara, Yoshinobu Eishi, Hidehiro Mizusawa, Takanori Yokota.   

Abstract

A 53-year-old man was admitted for sub-acute progressive dementia and Gerstmann syndrome. MRI demonstrated lesions in the white matter involving the left parietal lobe, accompanied by speckled or faint linear peripheral enhancement. Brain biopsy revealed JC virus infection in oligodendrocytes and balanced infiltration of CD8+ and CD4+ T lymphocytes. We diagnosed progressive multifocal leukoencephalopathy (PML) with controlled inflammation. The finding of CD4/CD8 T cells in the infected PML brain suggested therapeutically valuable immune system involvement, which we decided to preserve by withholding corticosteroids. We treated the patient with risperidone, cytarabine and mefloquine to suppress virus replication, but not with the corticosteroid that is conventionally used in inflammatory PML cases. The patient was discharged three months after admission, and one year later, his score on the Mini-Mental State Examination had recovered to 26/30, from 5/30 on admission.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27301518     DOI: 10.2169/internalmedicine.55.6051

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Authors:  Nobuo Sanjo; Yurie Nose; Yukiko Shishido-Hara; Saneyuki Mizutani; Yoshiki Sekijima; Hitoshi Aizawa; Toru Tanizawa; Takanori Yokota
Journal:  J Neurol       Date:  2018-12-03       Impact factor: 4.849

2.  The Effect of Intravenous Methylprednisolone on Recurrent Exacerbation in Hematologic Malignancy-associated Progressive Multifocal Leukoencephalopathy.

Authors:  Ryutaro Nakamura; Akihiro Kitamura; Takahito Tsukamoto; Ryota Tamura; Nobuhiro Ogawa; Isamu Yamakawa; Hyoh Kim; Michihiro Kawai; Mitsuru Sanada; Makoto Urushitani
Journal:  Intern Med       Date:  2020-11-23       Impact factor: 1.271

3.  Early Pathological JC Virus Lesions in a Patient without Any MRI-based Indications.

Authors:  Nobuo Sanjo; Yurie Nose; Shouhei Miyamoto; Yukiko Shishido-Hara; Tatsuya Saito; Tetsuya Fukuda; Kurara Yamamoto; Daisuke Kobayashi; Takanori Yokota
Journal:  Intern Med       Date:  2020-11-09       Impact factor: 1.271

4.  Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis.

Authors:  Mamiko Anada; Miyoka Tohyama; Yoshitaka Oda; Yuuta Kamoshima; Itaru Amino; Fumihito Nakano; Yusei Miyazaki; Sachiko Akimoto; Naoya Minami; Seiji Kikuchi; Satoshi Terae; Masaaki Niino
Journal:  Intern Med       Date:  2020-05-23       Impact factor: 1.271

Review 5.  The Use of Antimalarial Drugs against Viral Infection.

Authors:  Sarah D'Alessandro; Diletta Scaccabarozzi; Lucia Signorini; Federica Perego; Denise P Ilboudo; Pasquale Ferrante; Serena Delbue
Journal:  Microorganisms       Date:  2020-01-08

6.  Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.

Authors:  Ryusei Nishigori; Yoko Warabi; Yukiko Shishido-Hara; Kazuo Nakamichi; Yasuhiro Nakata; Takashi Komori; Eiji Isozaki
Journal:  Intern Med       Date:  2019-07-31       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.